Paper39458124
Treatment Strategies' Impact on Progression-Free Survival According to RMST Function in Metastatic Colorectal Cancer Patients: A Retrospective Study from Romania.
Pirvu EE and 7 others. J Clin Med, 2024. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Treatment Strategies' Impact on Progression-Free Survival According to RMST Function in Metastatic Colorectal Cancer Patients: A Retrospective Study from Romania. Papers, record 39458124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39458124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Treatment Strategies' Impact on Progression-Free Survival According to RMST Function in Metastatic Colorectal Cancer Patients: A Retrospective Study from Romania.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25844824 | Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study. | Am J Clin Oncol | 2017 | https://conductscience.org/library/papers/25844824 | PubMed |
| 2 | 19124802 | KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19124802 | PubMed |
| 3 | 32140476 | Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy. | Hepatobiliary Surg Nutr | 2020 | https://conductscience.org/library/papers/32140476 | PubMed |
| 4 | 20856756 | Chemotherapy treatments for metastatic colorectal cancer: is evidence-based medicine in practice? | J Oncol Pract | 2008 | https://conductscience.org/library/papers/20856756 | PubMed |
| 5 | 15166961 | Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. | Ann Surg | 2004 | https://conductscience.org/library/papers/15166961 | PubMed |
| 6 | 26818619 | Global patterns and trends in colorectal cancer incidence and mortality. | Gut | 2017 | https://conductscience.org/library/papers/26818619 | PubMed |
| 7 | 35003738 | Inoperable de novo metastatic colorectal cancer with primary tumour in situ: Evaluating discordant responses to upfront systemic therapy of the primary tumours and metastatic sites and complications arising from primary tumours (experiences from an Irish Cancer Centre). | Mol Clin Oncol | 2022 | https://conductscience.org/library/papers/35003738 | PubMed |
| 8 | 19022550 | The effect of socioeconomic status on survival from colorectal cancer in the Melbourne Collaborative Cohort Study. | Soc Sci Med | 2009 | https://conductscience.org/library/papers/19022550 | PubMed |
| 9 | 37761297 | Correlations between Demographic, Clinical, and Paraclinical Variables and Outcomes in Patients with KRAS-Mutant or KRAS Wild-Type Metastatic Colorectal Cancer-A Retrospective Study from a Tertiary-Level Center in Romania. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37761297 | PubMed |
| 10 | 37285096 | Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. | Ann Surg Oncol | 2023 | https://conductscience.org/library/papers/37285096 | PubMed |
| 11 | 19679400 | Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer. | Pathol Res Pract | 2009 | https://conductscience.org/library/papers/19679400 | PubMed |
| 12 | 34716838 | Management of Colorectal Cancer with Synchronous Liver Metastases: An Inception Cohort Study (CoSMIC). | Ann Surg Oncol | 2022 | https://conductscience.org/library/papers/34716838 | PubMed |
| 13 | 34663410 | Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34663410 | PubMed |
| 14 | 18316791 | Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18316791 | PubMed |
| 15 | 31972237 | Precision Therapy in RAS Mutant Colorectal Cancer. | Gastroenterology | 2020 | https://conductscience.org/library/papers/31972237 | PubMed |
| 16 | 23177514 | Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. | Lancet | 2013 | https://conductscience.org/library/papers/23177514 | PubMed |
| 17 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 18 | 21611958 | The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. | Stat Med | 2011 | https://conductscience.org/library/papers/21611958 | PubMed |
| 19 | 10493478 | Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. | Ann Surg | 1999 | https://conductscience.org/library/papers/10493478 | PubMed |
| 20 | 22696357 | Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. | Cochrane Database Syst Rev | 2012 | https://conductscience.org/library/papers/22696357 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| KRAS | 3845 | PubTator's text mining | https://conductscience.org/library/genes/3845 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39458124
GET https://conductscience.org/api/papers/v1/39458124/references?page=2